NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders

Stock Information for NanoVibronix Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NanoVibronix Inc.

NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan
NanoVibronix Issues Letter to Stockholders
NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract Award
NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024
NanoVibronix Issues Letter to Stockholders
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
NanoVibronix Featured in Your Bladder Health Magazine

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.